Role of 10-Gy boost radiation after breast-conserving surgery for stage I-II breast cancer with a 5-mm negative margin

被引:6
|
作者
Notani, Masafumi [1 ]
Uchida, Nobue [1 ]
Kitagaki, Hajime [1 ]
机构
[1] Shimane Univ, Fac Med, Dept Radiol, Izumo, Shimane 6938501, Japan
关键词
boost radiation; breast cancer; breast-conserving therapy; negative margin;
D O I
10.1007/s10147-007-0673-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background According to the Guidelines for breast-conserving therapy of the Japanese Breast Cancer Society, the surgical margin is "negative" when the minimum distance between the tumor edge and the margin of the resected specimen is more than 5mm. The value of boost radiation for early breast cancer with a 5-mm negative margin remains unclear. Methods. A total of 137 patients with stage I-II breast cancer underwent breast-conserving surgery between July 1987 and August 2002. All of the patients had negative margins according to the Japanese guidelines. Their median age was 50 years and the median follow-up period was 62 months. The entire ipsilateral breast was irradiated to a total dose of 50 Gy (25 fractions). Then an additional 10 Gy (5 fractions) was given to 79 patients, using 6- to 12-MeV electrons (boost group), while 58 patients (no-boost group) received no further radiation. Factors influencing local recurrence were evaluated by univariate and multivariate analyses. Results. For the entire population, the 5-year overall survival, cause-specific survival, disease-free survival, and local recurrence rates were 96.0%, 96.8%, 94.2%, and 1.67%, respectively. Boost radiation reduced local recurrence, but the improvement was not significant (P = 0.070). Univariate and multivariate analyses failed to detect any factors that were significantly associated with local control. There were no severe complications in either group and there were no differences between the groups in the cosmetic outcome. Conclusion. Boost radiation can be performed for stage I-II breast cancer with negative margins (Japanese guidelines), and showed a tendency to decrease local recurrence. A large randomized controlled study is necessary to establish final conclusions.
引用
收藏
页码:261 / 267
页数:7
相关论文
共 50 条
  • [21] Disparities in the Application of Adjuvant Radiotherapy After Breast-Conserving Surgery for Early Stage Breast Cancer
    Dragun, Anthony E.
    Huang, Bin
    Tucker, Thomas C.
    Spanos, William J.
    CANCER, 2011, 117 (12) : 2590 - 2598
  • [22] Intraoperative boost radiation effects on early wound complications in breast cancer patients undergoing breast-conserving surgery
    Gulcelik, Mehmet Ali
    Dogan, Lutfi
    Karaman, Niyazi
    Turan, Mujdat
    Kahraman, Yavuz Selim
    Akgul, Gokhan Giray
    Ozaslan, Cihangir
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2017, 47 (04) : 1185 - 1190
  • [23] Positive margin rates following breast-conserving surgery for stage I-III breast cancer: palpable versus nonpalpable tumors
    Atkins, Jordan
    Al Mushawah, Fatema
    Appleton, Catherine M.
    Cyr, Amy E.
    Gillanders, William E.
    Aft, Rebecca L.
    Eberlein, Timothy J.
    Gao, Feng
    Margenthaler, Julie A.
    JOURNAL OF SURGICAL RESEARCH, 2012, 177 (01) : 109 - 115
  • [24] Outcomes in breast cancer patients relative to margin status after treatment with breast-conserving surgery and radiation therapy: The University of Pennsylvania experience
    Peterson, ME
    Schultz, DJ
    Reynolds, C
    Solin, LJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 43 (05): : 1029 - 1035
  • [25] Local tumor control and cosmetic outcome following breast-conserving surgery and radiation up to a total dose of 56 Gy without boost in breast cancer patients
    Bayerl, A
    Frank, D
    Lenz, A
    Höss, C
    Lukas, P
    Feldmann, HJ
    Molls, M
    STRAHLENTHERAPIE UND ONKOLOGIE, 2001, 177 (01) : 25 - 32
  • [26] Higher 10-Year Survival with Breast-Conserving Therapy over Mastectomy for Women with Early-Stage (I-II) Breast Cancer: Analysis of the CDC Patterns of Care Data Base
    Shrestha, Pratibha
    Hsieh, Mei-Chin
    Ferguson, Tekeda
    Peters, Edward S.
    Trapido, Edward
    Yu, Qingzhao
    Chu, Quyen D.
    Wu, Xiao-Cheng
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2024, 18
  • [27] 1998-1999 patterns of care study process survey of national practice patterns using breast-conserving surgery and radiotherapy in the management of stage I-II breast cancer
    Pierce, LJ
    Moughan, J
    White, J
    Winchester, DP
    Owen, J
    Wilson, JF
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (01): : 183 - 192
  • [28] Racial disparities and trends in radiation therapy after breast-conserving surgery for early-stage breast cancer in women, 1992 to 2002
    Du, Xianglin L.
    Gor, Beverly J.
    ETHNICITY & DISEASE, 2007, 17 (01) : 122 - 128
  • [29] Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma
    Thurman, SA
    Schnitt, SJ
    Connolly, JL
    Gelman, R
    Silver, R
    Harris, JR
    Recht, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (01): : 152 - 159
  • [30] Racial disparities and trends in radiation therapy after breast-conserving surgery for early-stage breast cancer in women, 1992 to 2002
    Du, Xianglin L.
    Gor, Beverly J.
    ETHNICITY & DISEASE, 2006, 16 (01) : 122 - 128